Amelioration of Tissue Fibrosis by Toll-like Receptor 4 Knockout in Murine Models of Systemic Sclerosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amelioration of Tissue Fibrosis by Toll-like Receptor 4 Knockout in Murine Models of Systemic Sclerosis
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 67, Issue 1, Pages 254-265
Publisher
Wiley
Online
2014-10-09
DOI
10.1002/art.38901
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
- (2014) Suzana Jordan et al. ANNALS OF THE RHEUMATIC DISEASES
- Toll-Like Receptor 4 Signaling Augments Transforming Growth Factor-β Responses
- (2012) Swati Bhattacharyya et al. AMERICAN JOURNAL OF PATHOLOGY
- Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis
- (2012) Korsa Khan et al. ANNALS OF THE RHEUMATIC DISEASES
- Potential roles of interleukin-17A in the development of skin fibrosis in mice
- (2012) Yoshinobu Okamoto et al. ARTHRITIS AND RHEUMATISM
- T cells in systemic sclerosis: a reappraisal
- (2012) S. O'Reilly et al. RHEUMATOLOGY
- Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma
- (2011) Shun Kitaba et al. AMERICAN JOURNAL OF PATHOLOGY
- Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44
- (2011) Yuejuan Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR4 dependent heparan sulphate-induced pancreatic inflammatory response is IRF3-mediated
- (2011) Hamid Akbarshahi et al. Journal of Translational Medicine
- Future treatments in systemic sclerosis
- (2010) Yoshihide ASANO JOURNAL OF DERMATOLOGY
- Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
- (2010) Mark S. Wilson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cell Adhesion Molecules Regulate Fibrotic Process via Th1/Th2/Th17 Cell Balance in a Bleomycin-Induced Scleroderma Model
- (2010) A. Yoshizaki et al. JOURNAL OF IMMUNOLOGY
- The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
- (2010) Y. Shima et al. RHEUMATOLOGY
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Innate immunity and inflammation in systemic sclerosis
- (2009) Robert Lafyatis et al. CURRENT OPINION IN RHEUMATOLOGY
- CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced Scleroderma
- (2008) Ayumi Yoshizaki et al. AMERICAN JOURNAL OF PATHOLOGY
- Interleukin-17 Promotes Autoimmunity by Triggering a Positive-Feedback Loop via Interleukin-6 Induction
- (2008) Hideki Ogura et al. IMMUNITY
- Clinical Significance of Serum HMGB-1 and sRAGE Levels in Systemic Sclerosis: Association with Disease Severity
- (2008) Ayumi Yoshizaki et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Increased Serum Soluble OX40 in Patients with Systemic Sclerosis
- (2008) Kazuhiro Komura et al. JOURNAL OF RHEUMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started